Literature DB >> 2546493

Quinolone resistance in clinical isolates of Serratia marcescens.

K Fujimaki1, T Fujii, H Aoyama, K Sato, Y Inoue, M Inoue, S Mitsuhashi.   

Abstract

The uptakes of norfloxacin by quinolone-resistant and -susceptible strains of Serratia marcescens were almost the same and 50% inhibitory concentrations for DNA gyrase and the MICs of quinolones were correlated, suggesting that DNA gyrase alterations are the basis of quinolone resistance.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2546493      PMCID： PMC172536          DOI： 10.1128/AAC.33.5.785

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  DNA gyrase: an enzyme that introduces superhelical turns into DNA.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

2.  Ciprofloxacin-resistant Pseudomonas.

Authors:  C M Roberts; J Batten; M E Hodson
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

3.  Clinical resistance to long-term oral ciprofloxacin.

Authors:  S M Crook; J B Selkon; P D McLardy Smith
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

4.  Isolation of outer membrane proteins of Escherchia coli and their characterization on polyacrylamide gel.

Authors:  J Uemura; S Mizushima
Journal:  Biochim Biophys Acta       Date:  1975-12-01

5.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

6.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

7.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.

Authors:  M Kresken; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

9.  Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.

Authors:  T Sawai; R Hiruma; N Kawana; M Kaneko; F Taniyasu; A Inami
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties.

Authors:  W L Staudenbauer; E Orr
Journal:  Nucleic Acids Res       Date:  1981-08-11       Impact factor: 16.971
View more
  10 in total

1.  Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

Authors:  B L Masecar; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.

Authors:  M López-Brea; T Alarcón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

3.  Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens.

Authors:  Ayush Kumar; Elizabeth A Worobec
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.

Authors:  H Fukuda; M Hosaka; K Hirai; S Iyobe
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.

Authors:  J H Kim; E H Cho; K S Kim; H Y Kim; Y M Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

6.  Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors:  W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.

Authors:  P Heisig; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

8.  Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.

Authors:  Hideaki Maseda; Yumiko Hashida; Rumi Konaka; Akihiro Shirai; Hiroki Kourai
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

9.  Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.

Authors:  R Coria-Jiménez; C Ortiz-Torres
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

Review 10.  Do we need an intravenous fluoroquinolone?

Authors:  D S Maddix; L Warner
Journal:  West J Med       Date:  1992-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.